HemaSphere (Aug 2023)

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY

  • Talha Munir,
  • Mazyar Shadman,
  • Tadeusz Robak,
  • Jennifer R. Brown,
  • Brad Kahl,
  • Paolo Ghia,
  • Krzysztof Giannopoulos,
  • Martin Simkovic,
  • Anders Österberg,
  • Luca Laurenti,
  • Patricia Walker,
  • Stephen Opat,
  • Hanna Ciepluch,
  • Richard Greil,
  • Merit Hanna,
  • Monica Tani,
  • Marek Trneny,
  • Danielle M. Brander,
  • Ian W. Flinn,
  • Sebastian Grosicki,
  • Emma Verner,
  • Alessandra Tedeschi,
  • Sophie De Guibert,
  • Gayane Tumyan,
  • Kamel Laribi,
  • Jose Antonio Garcia Marco,
  • Jianyong LI,
  • Tian Tian,
  • Vanitha Ramakrishnan,
  • Yu Liu,
  • Andy Szeto,
  • Jason Paik,
  • Aileen Cohen,
  • Constantine Tam,
  • Wojciech Jurczak

DOI
https://doi.org/10.1097/01.HS9.0000969460.15364.af
Journal volume & issue
Vol. 7
p. e15364af

Abstract

Read online

No abstracts available.